The oral cancer tissues exhibited variable cytoplasmic expressions of Beclin 1 and Beclin 2, ranging from total loss to diffuse strong expression (Fig 1B–1D and 1F–1H). This evidence concerns the gene BECN2 and lip and oral cavity carcinoma.